Related Experiment Video
Updated: Sep 19, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Menopausal hormone therapy: Making sense of current guidelines
1At the time this article was written, Ashley Church was a student at the University of Nevada, Reno School of Medicine Physician Assistant Studies Program in Reno, Nev.; she now practices primary care at Western Sierra Medical Center in Grass Valley, Calif. Megan Biagi is an associate professor in the Department of Family and Community Medicine at the University of Nevada, Reno School of Medicine Physician Assistant Studies Program. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Menopausal hormone therapy (MHT) effectively treats menopause symptoms and may reduce cardiovascular risk. Current guidelines support an evidence-based, patient-centered approach for optimal menopausal care in select individuals.
Area of Science:
- Menopause Management
- Hormone Therapy Research
- Women's Health
Background:
- Menopausal hormone therapy (MHT) is a primary treatment for vasomotor and genitourinary symptoms.
- Recent evidence suggests MHT may offer cardiovascular and mortality benefits in specific populations.
Purpose of the Study:
- To provide a comprehensive overview of current guidelines for MHT use.
- To advocate for an evidence-based, patient-centered approach to menopausal care.
Main Methods:
- Review of emerging evidence and current clinical guidelines.
- Synthesis of data on MHT efficacy, safety, and risk-benefit profiles.
- Focus on patient-centered and evidence-based care strategies.
Main Results:
- MHT is confirmed as the most effective treatment for menopausal symptoms.
- Initiating MHT in appropriate candidates shows a favorable risk-benefit profile.
- MHT is associated with reduced cardiovascular disease risk and all-cause mortality.
Conclusions:
- MHT offers significant benefits for managing menopausal symptoms.
- An evidence-based, patient-centered approach is crucial for optimizing MHT use.
- Guidelines support MHT for specific patient populations, enhancing menopausal care.
More Related Videos
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Hormonal Regulation
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Therapy
Antianxiety Medications

